ArticleScientific reports2024
Fabrication of nanocomposite membranes containing Ag/GO nanohybrid for phycocyanin concentration.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
In this research, silver/graphene oxide (Ag/GO) nanohybrid was first synthesized and used in production of polysulfone (PSF) ultrafiltration (UF) membranes via phase inversion method for concentrating phycocyanin (PC) and treating methylene blue (MB) dye effluent. Designing the experiment (DOE) using Box-Behnken method by Design Expert software helped to calculate the optimal values of the variables under study. The studied variables included PSF polymer concentration, polyvinyl pyrrolidone (PVP) pore-former concentration and Ag/GO nanohybrid content, which were investigated for their effects on pure water flux (PWF) and MB pigment rejection. According to the results of the DOE, the membrane containing 19.485 wt% PSF, 0.043 wt% PVP and 0.987 wt% Ag/GO was selected as the optimal membrane. Due to the high price of PC as drug, and the importance of removing MB pigment from the effluent of dyeing and textile industries, the membranes were first optimized with MB pigment and then the optimal membrane was used for concentrating PC. The results showed that PWF reaches from 40.05 L.m
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.